BRIDGE
Biopharmaceutical Research Innovations and Development of Global Enterprises
The Third Annual Conference of CBA Canada
October 8th, 2022, Saturday
Venue: Downtown Montreal | Online: Zoom (Hybrid meeting)
About the Conference
This year, the theme of the CBA Canada annual conference is “BRIDGE: Biopharmaceutical Research Innovations and Development of Global Enterprises”. The theme has been carefully selected to emphasize CBA-Canada’s primary mission: bridging biopharmaceutics between Canada, USA and China, and addressing the critical importance of new technology and worldwide collaboration for the development of global biopharmaceuticals in these countries. The conference provides a perfect communication venue for people from academia, industries, government agencies and investment companies.
Presentation Topics
We will focus on the following topics in the Annual Conference of 2022.
2022 Confirmed Speakers (Update Weekly)
Dr. Shoubai Chao
Dr. Shou-Bai Chao is currently Chief Operations Officer of CanSino Biologics Inc. (6185.HK/688185SH). He is a senior executive and well-sought industry leader who brings comprehensive perspective with more than 30 years’ experience from AstraZeneca, Wyeth, Sanofi-Pasteur and Genentech in global vaccine and biopharmaceutical process and product development, manufacturing operations, quality assurance and business management. Dr. Chao is the former Senior Vice President at AstraZeneca (MedImmune). Prior to joining CanSinoBIO in 2018, Dr. Chao was leading AstraZeneca’s Bio-ventures business unit to develop Biosimilars and BioBetters for global markets, working with leading biotech companies in US, Europe, China and other Asian countries.
Title: Advances in COVID19 vaccine development
Dr. May Griffith
Dr. May Griffith is a Professor at the Department of Ophthalmology, University of Montreal. She holds the Canada Research Chair in Biomaterials and Stem Cells in Ophthalmology and Caroline Durand Foundation Research Chair in Cellular Therapy of the Eye. She is currently Director of the Cornea and Anterior Segment Axis of the Quebec Vision Health Research Network. Dr. Griffith is known for her pioneering work in translational regenerative medicine and in situ tissue regeneration. Dr. Griffith and her team developed the world’s first cell-free biosynthetic corneal implants that promoted human corneal tissue and nerve regeneration in a human clinical trial in Sweden. Since then, she and Virender Sangwan completed a second clinical trial with biosynthetic corneal implants containing an inflammation-suppressing polymer network on high-risk patients. Dr. Griffith continues her bench-to-bedside work in cornea regeneration, developing biomimetic biomaterials for regenerative medicine to meet unmet medical needs.
Title: Biosynthetic Corneas and the Potential for Vision Restoration
Dr. Janos G Filep
Dr. Filep, M.D. degree. Since 2003, he is a full professor in the Department of Pathology and Cell Biology, Université de Montréal. Dr. Filep has a longstanding interest in the function of innate immunity and cardiovascular diseases (vascular immunology), with focus on acute coronary artery disease, sepsis and acute respiratory distress syndrome. His team is currently studying mechanisms and mediators that govern the resolution phase of inflammation, and the fate of emigrated neutrophils in particular. Dr. Filep has published over 200 peer-reviewed articles in leading journals, including Blood, Circulation, J Clin Invest, Nature Comm, Mol Aspects Med and PNAS, and over 30 book chapters. His h-index is 73.
Title: Resolution biology: novel approaches for the treatment of inflammatory diseases
Dr. Guojun Chen
Dr. Guojun Chen is an Assistant Professor in the Department of Biomedical Engineering and a full member of the Rosalind & Morris Goodman Cancer Institute (GCI)at McGill University. Dr. Chen was a postdoctoral researcher working with Prof. Gu at UCLA during 2018 to 2020. Dr. Chen joined McGill University in 2021. His research focuses on engineering novel biomaterials and devices for drug delivery, especially for enhanced cancer immunotherapy and gene therapy, with the ultimate goal towards precision medicine. He has published over 70 peer-reviewed research papers, including in Nature Nanotechnology, PNAS, Nature Biomedical Engineering, and Science Advances. He is the recipient of the Young Investigator award from the Chinese Association for Biomaterials and the FRQS-Career Award (Junior 1).
Title: Engineering nanoformulations and microdevices for drug delivery
Dr. Jian Tang
Dr.
Title: Geometric Deep Learning for Antibody Design
Dr. Lianglu Zhang
Dr. Lianglu Zhang, PhD, General manager and chairman of Wuhan Amison Life Technology Co.,Ltd., graduated from Wuhan University, alumnus of China Europe International Business School.
He is a leading talent of Ministry of Industry and Information Technology, 3351 entrepreneurial talents of Optics Valley, Young talents of Hubei Province, Member of the Collaborative Group on gastric cancer markers of the Chinese anticancer association, Member of molecular diagnosis expert committee, Vice chairman of science popularization and teaching special committee of Hubei Immunology Society, Director of Hubei Society for clinical evaluation of drugs and medical devices.
Title: An exact solution to prevent CRC in early stage
Mr. Guangli Wang
Mr. Guangli Wang is President of Zhongguancun Science Centre Inc., the Canadian liaison office of Zhongguancun Science Park which is the largest and the most important science park in China and often dubbed as China’s Silicon Valley. He is responsible for the overall management of the office based in Markham but with services reaching out to all major high-tech innovative cities all over Canada. His main work includes presenting and explaining to the locals about the Zhongguancun Science Park specific polices to foster industries and attract more human resources back to the science park to prosper, liaising the local resources to establish good relationship with them, and offering services to those people when they make up their minds to start up business in Zhongguancun Science Park. Prior to the current position, he once worked at the central and local governments in China and Deloitte China as a manager at the Marketing and Business Development Department.
He holds a Master’s degree in Civil and Commercial Law and a Master’s degree in Linguistics from Renmin University of China. He has also received a postgraduate certificate in Supply Chain Management from Humber College.
Title: An Intro to Zhongguancun (ZGC) Science Park in China
Montréal International
Greater Montréal’s economic promotion agency
Title: TBD
Mr. Kelvin K Mo
Mr. Kelvin K Mo is a senior consultant in business and management. He’s the founder and president of two companies: Global Health Service Group Inc. in 2008 and BCMMO Inc. in 2013 for serving his clients varies from the small & medium enterprises from the local, national and international scene.
He is the president of Board of director of Asia pacific SME and president of the Saint Laurent Mont Royal Chamber of Commerce and Industry. He is a business jury for chamber of commerce.
Title: Pharmaceutical in compliance of the GMP of health Canada
Mr. Lee Lai & Mr. Liborio Paci
Mr. Lee Lai & Mr. Liborio Paci are the Field Sales and managers from RBC Insurance.
Lee has Master’s degree in finance and have worked in the financial industry as a venture capital ,financial advisor, corporate finance manager, business consultant and business owner for 25 years . It has helped him to understand services and support that people or business owner’s need from both the advisor and client perspective. His strongest areas of expertise are in startup, business planning, risk management, financial planning, etc.
Mr. Liborio Paci worked in sales environment for more than 10 years. In 2014, he was awarded the Prix d’Excellence, and the following year the award of Quick Start Graduate. He has an Italian background, and being involved in the community is something very important in his culture. He have been implicated in many charitable events throughout my personal and professional life.
Title: Risk & wealth management method for employee or business owner in pharmacy company
More Top-Notched Speakers To Be Confirmed
As one of the most influential Chinese science and technology associations in North America, the founding branch of the Chinese Biopharmaceutical Association has invited various notable speakers in previous years. This includes Dr. Barry Marshall, winner of the 2005 Nobel Prize in Physiology or Medicine; Ms. Kelly Schulz, Maryland Secretary of Commerce; former U.S. Department of Labor Treasurer Mr. Samual T Mok; Chief Financial Officer of the Ministry of Labor, Ms. Monica Hughes; former Chief Program Manager of FDA CDER, Professor Chen Zhu; former Minister of Health of China, Professor Gao Fu; the current Director of the Chinese Center for Disease Control and Prevention, Dr. Simon Kos; Chief Medical Officer of Microsoft, and CEOs and presidents of well-known companies. Not only that, as the most influential Chinese Biopharmaceutical Association in Canada, CBA Canada has invited Zhang Mingrui, the “Father of Artificial Cells”; Dr. Liu Jian, CEO of BeiGene Bio-Island Innovation Center; Dr. Wang Rui, Dean of the Faculty of Science at York University; Gao Zuhua of the Canadian Academy of Health Sciences; Dr. Michele de Guise, Director of INESSS (Institut national d’excellence en santé et en services sociaux), and some other well-known scientists and executives of large corporations who have shared their academic achievements and industry insights.
Pricing
We will update the prices and registration link at the end of July, please check back later.
Conference Pass
Early Bird Price- 15% Discount for Early Registration
- The price including the conference pass with lunch box, coffee and snacks.
- Trainees with valid student ID get an extra 15% discount. (Code:STUDENTDISCOUNT)
Conference Pass+ Banquet
Early Bird Price- 15% Discount for Early Registration
- The price including the conference pass with lunch box, coffee, snacks and a banquet ticket.
- Trainees with valid student ID get an extra 15% discount. (Code:STUDENTDISCOUNT)
Conference Pass
Regular Price- The price including the conference pass with lunch box, coffee and snacks.
- Trainees with valid student ID get an extra 15% discount.(Code:STUDENTDISCOUNT)
Conference Pass + Banquet
Regular Price- The price including the conference pass with lunch box, coffee, snacks and a banquet ticket.
- Trainees with valid student ID get an extra 15% discount.(Code:STUDENTDISCOUNT)
About CBA Canada
The Canada Chapter of Chinese Biopharmaceutical Association, USA was incorporated in Montreal on January 17, 2019. CBA Canada is the Canadian branch of the Chinese Biopharmaceutical Association (CBA). The organization’s primary mission is to encourage communication and collaboration between Canadian Chinese and non-Chinese in biopharmaceutics. It is also a platform for exchanging innovative biopharmaceutical developments and technical cooperation between Canada, the United States and China. CBA Canada strives to provide a platform for distributing knowledge and promoting collaboration for scientists, entrepreneurs, and investors in the Canadian biopharmaceutical industry.
The Chinese Biomedical Technology Association (CBA) was established in 1995 and is headquartered in Potomac, Maryland. It currently has 8,000 employees and more than 60 institutional members. More than 80% of CBA members have doctorate degrees. Many of CBA’s members work at renowned institutions, research facilities, pharmaceutical companies, and top universities in the world, including the FDA, National Institutes of Health, Johns Hopkins University, George Washington University, Georgetown University, and University of Maryland. In addition to members from the United States, CBA also has Chinese members from China, Europe, Canada, Australia, Singapore and Japan.
Sponsors
Thanks to our sponsors for their generous donation and support.
Jiangsu Hualan New Pharmaceutical Materials Co., Ltd.
Jiangsu Hualan New Pharmaceutical Materials Co., Ltd.established in 1992. After nearly 30 years of unremitting efforts, has developed into a national high-tech enterprise with advanced technologies and substantial product variety, specializing in R & D, manufacturing and sales of primary packaging materials for a wide range of injectable medications. The company’s main products are butyl rubber stoppers, coated rubber stoppers, pre-filled syringe components and silicone sealing elastomers used for high, high-end injections in the world and China .
Collaboration Request
The growth of the CBA Canada Association and the success of events are inseparable from the support of the sponsors and partners. We welcome any type of collaborations.
Please contact Dr. William Wang for sponsor benefits and any other collaboration inquires: William.Wang@cba-usa.org
Reach Us
For general inquires of CBA Canada, please contact us via email, Wechat, Facebook or Linkedin
Montreal, Canada
Rui.Li@cba-usa.org
